Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

TRIFERIC AVNU

FERRIC PYROPHOSPHATE CITRATE

Standard Dose
6.75MG IRON/4.5ML (1.5MG IRON/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRIFERIC AVNU is listed in Drugs@FDA under application 212860 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength SOLUTION;INTRAVENOUS - 6.75MG IRON/4.5ML (1.5MG IRON/ML) Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2023-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIFERIC AVNU is listed in Drugs@FDA under application 212860 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength SOLUTION;INTRAVENOUS - 6.75MG IRON/4.5ML (1.5MG IRON/ML) Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2023-07-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.